Press Releases July 1, 2026 08:00 AM

Stryker to announce second quarter 2026 financial results

Stryker schedules webcast to announce Q2 2026 financial results on July 30

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
SYK

Stryker Corporation, a global leader in medical technologies, announced it will webcast its second quarter 2026 financial results on July 30, 2026. The company will issue a press release with summary financial information prior to the webcast. Stryker's products span MedSurg, Neurotechnology, and Orthopaedics, impacting over 150 million patients annually worldwide.

Stryker to announce second quarter 2026 financial results
SYK
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Stryker will host a webcast on July 30, 2026, to discuss Q2 financial results.
  • A press release summarizing Q2 financials will be issued before the webcast.
  • Stryker is a major player in medical technologies including MedSurg, Neurotechnology, and Orthopaedics sectors.

Portage, Michigan, July 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, July 30, 2026, to discuss its second quarter 2026 financial results.  The live webcast can be accessed at Stryker - Events & Presentations.  An archive of the webcast will also be available at Stryker’s website beginning approximately two hours after the live call ends.

An accompanying press release that includes summary financial information for the second quarter will be issued at approximately 4:05 p.m. (Eastern time) and available at Stryker - Press Releases on the day of the webcast.

About Stryker

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

Contacts

For investor inquiries:
Nick Mead, Vice President, Investor Relations at 269-385-2600 or [email protected]

For media inquiries:
Kim Montagnino, Vice President, Chief Communications Officer at 269-385-2600 or [email protected]


Risks

  • Uncertainty of financial performance results which could affect investor sentiment.
  • Potential market volatility around the earnings announcement date.
  • Broader healthcare sector regulatory or reimbursement changes impacting business results.

More from Press Releases

GSR V Acquisition Corp. Announces the Separate Trading of its Shares of Class A Ordinary Shares and Commencing July 2, 2026 Jul 1, 2026 High Income Securities Fund Announces Monthly Distributions For Third Quarter of 2026 Jul 1, 2026 Provident Financial Services, Inc. Schedules Second Quarter Earnings Conference Call Jul 1, 2026 Tenable Named as the Current Company to Beat for AI-Powered Exposure Assessment in a June 2026 Gartner® Report Jul 1, 2026 NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes Jul 1, 2026